Clinical Trial Update: Vildagliptin Compared to Gliclazide as Dual Therapy With Metformin in Muslim Patients With Type 2 Diabetes Fasting During Ramadan [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing vildagliptin to gliclazide as add-on therapy to metformin in Muslim patients with type 2 diabetes during Ramadan has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Gliclazide (gliclazide)
• Vildagliptin (vildagliptin)
• metformin (metformin)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED